In tiny amounts, in a slow-release formulation that efficiently penetrates nerves, the toxin provided a safe, highly targeted, long-lived nerve block in the animals, researchers reported June 12 in Nature Communications.
The study was led by Daniel Kohane, Harvard Medical School professor of anesthesia at Boston Children’s Hospital.
Kohane has long been interested in neurotoxins found in marine organisms like pufferfish and algae. In small amounts, they could provide potent pain relief, blocking the sodium channels that conduct pain messages, he says.
Kohane’s lab has experimented with various ways of packaging and delivering these compounds in tiny particles, such as activating local drug release with ultrasound and near-infrared light.
Taming a lethal toxin
For the new study, the team chose tetrodotoxin, a potent, commercially available compound derived from pufferfish. Tetrodotoxin is notorious for causing fugu poisoning from improperly prepared sashimi.
Rather than load the toxin into particles as before, the team bound it chemically to a polymer “backbone.”
The body very slowly degrades the bond between tetrodotoxin and the polymer via hydrolysis, the natural breaking of chemical bonds by water. This releases the drug at a slow, safe rate.
Chao Zhao and Andong Liu, research fellows in the Kohane lab and co-first authors of the paper, experimented with different drug loadings and polymer formulations to get the longest-possible nerve block with the least toxicity.
Pairing the tetrodotoxin-polymer combination with a chemical penetration enhancer—a compound that made the nerve tissue more permeable—allowed the team to use even smaller amounts of tetrodotoxin.
“Each bit of drug you put in packs the most punch possible,” said Kohane.
“Both the penetration enhancer and the reversible bonding of toxin to polymer are crucial to achieving such prolonged anesthesia,” said Liu.
When the researchers injected the combination near the sciatic nerve in rats, they achieved a nerve block for up to three days, with minimal local or systemic toxicity and no apparent sign of tissue injury.
In theory, nerve block in humans could last even longer, since one could administer it more safely than in rats, said Kohane. Using polymers with a longer retention time in tissue would also prolong effects.
“We could think about very long durations of nerve block for patients with cancer pain, for example,” he said. “Certainly for days, and maybe for weeks.”
More work needs to be done before it becomes clear whether the method tested in rats would be safe and effective in humans.